Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
Ran Jing, Irene Scarfo, Mohamad Najia, et al.
Cell stem cell (2022) Vol. 29, Iss. 8, pp. 1181-1196.e6
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Humanized mouse models for immuno-oncology research
Jane Chuprin, Hannah Buettner, Mina O. Seedhom, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 192-206
Open Access | Times Cited: 166
CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 66
Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators
Wanyu Tao, Zhengqing Yu, Jing‐Dong J. Han
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 1126-1143.e5
Closed Access | Times Cited: 39
The immunology of systemic lupus erythematosus
George C. Tsokos
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1332-1343
Closed Access | Times Cited: 26
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
Yue Huang, Mi Shao, Xinyi Teng, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101400-101400
Open Access | Times Cited: 19
Generating human bone marrow organoids for disease modeling and drug discovery
Aude-Anaïs Olijnik, Antonio Rodriguez-Romera, Zoë C. Wong, et al.
Nature Protocols (2024) Vol. 19, Iss. 7, pp. 2117-2146
Closed Access | Times Cited: 16
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
Frank Cichocki, Sjoukje J. C. van der Stegen, Jeffrey S. Miller
Blood (2022) Vol. 141, Iss. 8, pp. 846-855
Open Access | Times Cited: 46
Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41
Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy
Dixuan Xue, Shan Lu, Hailing Zhang, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 7, pp. 907-922
Open Access | Times Cited: 40
Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy
Zhibo Zheng, Siyuan Li, Mohan Liu, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3476-3476
Open Access | Times Cited: 28
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation
Ratchapong Netsrithong, Laura García-Pérez, Maria Themeli
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 8
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
Zixin Lv, Fei‐Fei Luo, Yiwei Chu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
H3K27me3-mediated epigenetic regulation in pluripotency maintenance and lineage differentiation
Liwen Jiang, Linfeng Huang, Wei Jiang
Cell Insight (2024) Vol. 3, Iss. 4, pp. 100180-100180
Open Access | Times Cited: 6
Application of adoptive cell therapy in hepatocellular carcinoma
Dengqiang Wu, Yujie Li
Immunology (2023) Vol. 170, Iss. 4, pp. 453-469
Open Access | Times Cited: 16
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
Teng Zhang, Cheng Qian, Mengyao Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2680-2680
Open Access | Times Cited: 5
iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine
Kelvin K. Hui, Shinya Yamanaka
BioEssays (2024)
Closed Access | Times Cited: 5
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
Haiqiong Zheng, Yijin Chen, Qian Luo, et al.
Cell Regeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Jiepu Zong, Yan-Ruide Li
Bioengineering (2025) Vol. 12, Iss. 1, pp. 60-60
Open Access
Page 1 - Next Page

Scroll to top